Deals Shaping The Medical Industry, October 2020
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
You may also be interested in...
Big Pharma Must Diversify To Tackle Antimicrobial Resistance
Big pharma must bet on biotech if the industry is to tackle the looming issue of superbugs, argues the Access To Medicine Foundation.
Pink Sheet Podcast: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation, upcoming guidance on accelerated approval for gene therapies, and partisan attacks on the agency from Capitol Hill.
Beiersdorf Partners With Biopharma For Anti-Aging Skin Care Innovation; Beauty Business News
With NIVEA driving growth in its Consumer division, German firm Beiersdorf AG has signed a multi-year deal with Rubedo Life Sciences to develop anti-aging solutions and new products for the global market. More beauty business news, including L’Oreal, Inter Parfums, Galderma, and LVMH/Sephora sales updates.
| Table |
|---|